ea0056gp260 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018
Insull Elizabeth
, Turner Helen
, David Joel
, Norris Jonathan
Background: Thyroid eye disease (TED) is an autoimmune inflammatory disease that can be both disfiguring and potentially sight threatening. Suppression of inflammation in active disease can reduce the risk of visual loss and limit long-term sequelae of the disease. Current disease management involves suppression of inflammation using glucocorticoids. The aim of our study was to evaluate the efficacy of early disease intervention with targeted immunomodulatory therapy to alter ...